Inter-tumor heterogeneity and radiation dose-control curves

Area of Science:

• Radiation Oncology
• Tumor Biology
• Mathematical Modeling

Background:

• Clinical radiation therapy relies on dose-response curves, but inter-tumor heterogeneity complicates predictions.
• Individual tumors exhibit unique dose-control relationships (I-TCP/D), while population-level curves (H-TCP/D) are flatter due to summation.
• Tumor populations comprise sensitive, stochastic, and refractory fractions, influencing treatment outcomes.

Purpose of the Study:

• To theoretically analyze how inter-tumor heterogeneity affects clinical radiation dose-response curves.
• To elucidate the mathematical basis of heterogeneous dose-control relations (H-TCP/D) arising from individual tumor variations.
• To identify distinct tumor subclasses within a population and their implications for radiation therapy.

Main Methods:

• Theoretical analysis of dose-response relationships.
• Modeling of population-level tumor control probability (H-TCP/D) as a weighted sum of individual tumor control probabilities (I-TCP/D).
• Classification of tumors into sensitive, stochastic, and refractory fractions based on individual control probability.

Main Results:

• Inter-tumor heterogeneity results in a flatter H-TCP/D curve compared to steep I-TCP/D curves.
• A significant portion (70-85%) of treatment failures, at ~50% overall tumor control probability, originates from a radioresistant fraction.
• Tumor populations can be stratified into sensitive, stochastic, and refractory subclasses.

Conclusions:

• Predicting individual tumor response is essential for optimizing radiation therapy.
• Identifying tumors within the sensitive, stochastic, or refractory fractions can guide treatment strategies.
• Targeting radioresistant fractions is key to improving local tumor control in radiation oncology.